{
    "nctId": "NCT06475066",
    "briefTitle": "Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging",
    "officialTitle": "Clinical Effectiveness of cOntrast Enhanced Mammography in Diagnosis of Additional Findings at Preoperative Breast Magnetic ResOnance Imaging: A Prospective, Multicenter, Interventional Study",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 320,
    "primaryOutcomeMeasure": "The detection rate of preoperative contrast-enhanced spectral mammography",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 1. Adult women aged 18-75 years old\n* 2. First-time referral to the breast clinic or inpatient department of the study center for being diagnosed as presenting with suspicious breast lesions by previous procedures in 30 days\n* 3. Presenting with Index lesions of \"BI-RADS\u22654\" and additional findings in preoperative breast MRI\n* 4. Sign the informed consent form for this study.\n* 5. Commit to follow the research procedures and cooperate with the implementation of the whole process of the study.\n* 6. In the case of women of childbearing age, have been taken contraception for at least one month prior to screening and have had a negative serum or urine pregnancy test and commit to use contraception throughout the study period\n\nExclusion Criteria:\n\n* 1. Patients with contraindications of intravenous administration of iodine contrast agent, such as pregnant or lactating women, patients with a history of iodine contrast agent allergy, patients with obvious hyperthyroidism\n* 2. It has been more than 14 days since the most recent preoperative breast MRI was performed for the relevant breast disease\n* 3. For the relevant breast disease, the preoperative breast MRI images and reports received within 14 days before screening are not available or do not meet the requirements of clinical diagnosis\n* 4. Patients who is receiving non-surgical interventional treatment such as neoadjuvant chemotherapy, hormone therapy or radiation therapy\n* 5. Patients who have received any breast operation for the relevant disease, such as various biopsies, therapeutic breast surgery\n* 6. Other patients assessed by the investigators as not suitable for the study, such as those who are difficult to cooperate with CESM examination due to unconsciousness, communication disorder or/and small breasts to meet the examination requirements",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}